Core Laboratories Current Liabilities

CLB
 Stock
  

USD 21.68  0.87  4.18%   

Core Laboratories NV fundamentals help investors to digest information that contributes to Core Laboratories' financial success or failures. It also enables traders to predict the movement of Core Laboratories Stock. The fundamental analysis module provides a way to measure Core Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Core Laboratories stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
The current year Current Liabilities is expected to grow to about 96.4 M.

Core Laboratories Current Liabilities Analysis

Core Laboratories' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

Core Laboratories Current Liabilities

96.45 Million

Current Liabilities 
 = 
Payables 
Accrued Debt 
More About Current Liabilities | All Equity Analysis

Current Core Laboratories Current Liabilities

    
  120.76 M  
Most of Core Laboratories' fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Core Laboratories NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Core Laboratories Current Liabilities Driver Correlations

Understanding the fundamental principles of building solid financial models for Core Laboratories is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Current Liabilities. Since Core Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Core Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Core Laboratories' interrelated accounts and indicators.

Core Laboratories Current Liabilities Historical Pattern

Today, most investors in Core Laboratories Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Core Laboratories' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Core Laboratories current liabilities as a starting point in their analysis.
   Core Laboratories Current Liabilities   
Share
       Timeline  
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Compare to competition

Core Laboratories Total Liabilities

Total Liabilities

507.55 Million

Core Laboratories Total Liabilities is projected to increase significantly based on the last few years of reporting. The past year's Total Liabilities was at 419.85 Million
In accordance with the recently published financial statements, Core Laboratories NV has a Current Liabilities of 120.76 M. This is 98.37% lower than that of the Energy Equipment & Services sector and 89.26% lower than that of the Energy industry. The current liabilities for all United States stocks is 98.47% higher than that of the company.

Core Laboratories Current Valuation Drivers

We derive many important indicators used in calculating different scores of Core Laboratories from analyzing Core Laboratories' financial statements. These drivers represent accounts that assess Core Laboratories' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Core Laboratories' important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Average Assets582.93 M629.33 M783.91 M605.11 M587.5 M674.84 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA136.63 M141.39 M126.99 M(56.5 M)63.29 M64.95 M
Earnings Before Interest Taxes and Depreciation Amortization USD136.63 M141.39 M126.99 M(56.5 M)63.29 M64.95 M
Earnings before Tax101.37 M104.97 M89.69 M(91.74 M)35.62 M36.56 M
Average Equity147.78 M153.9 M184.88 M66.74 M151.23 M138.05 M
Enterprise Value5.06 B2.92 B2.03 B1.5 B1.27 B1.3 B
Free Cash Flow105.82 M89.78 M67.97 M47.22 M23.4 M24.02 M
Invested Capital508.38 M590.47 M802.9 M683.97 M615.05 M677.71 M
Invested Capital Average507.54 M568.48 M791.85 M711.4 M630.07 M676.48 M
Market Capitalization4.84 B2.64 B1.67 B1.18 B1.03 B1.06 B
Tangible Asset Value396.37 M416.36 M543.8 M460.55 M473.27 M512.29 M
Working Capital106.85 M128.43 M109.64 M76.1 M98.27 M103.68 M

Core Laboratories Fundamentals

About Core Laboratories Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Core Laboratories NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Core Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Core Laboratories NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2022
Current Liabilities90.8 M96.4 M

Be your own money manager

Our tools can tell you how much better you can do entering a position in Core Laboratories without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run CEO Directory Now

   

CEO Directory

Screen CEOs from public companies around the world
All  Next Launch Module
Continue to Core Laboratories Piotroski F Score and Core Laboratories Altman Z Score analysis. You can also try Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for analysis

When running Core Laboratories price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core Laboratories will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
7.47
Market Capitalization
965 M
Quarterly Revenue Growth YOY
0.068
Return On Assets
0.044
Return On Equity
9.19
The market value of Core Laboratories is measured differently than its book value, which is the value of Core Laboratories that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Core Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.